Home » Topics » Regulatory » Patents

Patents
RSS

Leukotriene antagonists from Sankyo

Oct. 18, 1996

Neuroprotective calpain inhibitors from Warner-Lambert

Oct. 18, 1996

Huperzine A analogues claimed for treatment of AD

Oct. 18, 1996

Lilly's benzimidazole compounds for beta-amyloid peptide-associated disorders

Oct. 18, 1996

Peptidomimetic compounds disclosed by University of Pennsylvania

Oct. 18, 1996

Antipsychotic agents from Asahi Chem.

Oct. 18, 1996

Schering AG discloses DTPA derivatives for diagnostic use

Oct. 18, 1996

Akzo patents new method for imaging infections

Oct. 18, 1996

New NPY antagonists from Warner-Lambert

Oct. 18, 1996

Warner-Lambert describes NK2 antagonists for obesity

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...